📦Darmowa dostawa od 69 zł - do Żabki oraz automatów i punktów GLS! Przy mniejszych zamówieniach zapłacisz jedynie 4,99 zł!🚚
Darmowa dostawa od 69,00 zł
Comparative Analysis and Benchmarking - Chen Hung-Hsin

Comparative Analysis and Benchmarking - Chen Hung-Hsin

  • Corporate Strategy Analysis of Four International Pharmaceutical Companies
This research of corporate strategy analysis implements comparative analysis and benchmarking to analyse and examine the corporate strategy of the pharmaceutical sectors of 4 international pharmaceutical companies. This research adopts the hybrid approach of combining qualitative and quantitative methods in a two stages research design. Quantitative method is applied first to deal with the comparative figures, and then qualitative method is used to find out the problem. The design of this multiple research includes three phases: data collection, analysis, and reporting. The findings of this research can be divided into 4 parts: R&D/marketing, technology alliances, strategic acquisitions and merger, and manufacturing. The drug innovative projects are recommended being developed within the company's familiar therapeutic areas in order to take its marketing advantage. Through this comparative analysis, some of this type of problems of these international pharmaceutical companies is identified. A big pharmaceutical company forming alliances with some small biotechnology companies has become a trend within pharmaceutical industry since 1980s. For pharmaceutical companies, to take advantage of R&D through biotechnology is the main purpose of alliances with small biotechnology companies. It is important to note that most pharmaceutical acquisitions belong to the type of absorption with high resource transferring and low autonomy. Due to the high profit margin and the essential importance of R&D and marketing, the operation management of manufacturing of pharmaceutical industry is relatively poor. The low asset utilisation rate pointed out this problem. Academic researches have revealed that existing theories of operation management of manufacturing, such as action research, set-up reduction, teamwork, continuous improvement, collaboration, and involvement, are applicable and beneficial to pharmaceutical industry rather than waiting for the technology breakthroughs.

EAN: 9781581121896
Symbol
308EYJ03527KS
Rok wydania
2003
Elementy
140
Format
18.9x24.6cm
Język
angielski
Więcej szczegółów
Bez ryzyka
14 dni na łatwy zwrot
Szeroki asortyment
ponad milion pozycji
Niskie ceny i rabaty
nawet do 50% każdego dnia
115,70 zł
/ szt.
Najniższa cena z 30 dni przed obniżką: / szt.
Cena regularna: / szt.
Możesz kupić także poprzez:
Do darmowej dostawy brakuje69,00 zł
Najtańsza dostawa 0,00 złWięcej
14 dni na łatwy zwrot
Bezpieczne zakupy
Kup teraz i zapłać za 30 dni jeżeli nie zwrócisz
Kup teraz, zapłać później - 4 kroki
Przy wyborze formy płatności, wybierz PayPo.PayPo - kup teraz, zapłać za 30 dni
PayPo opłaci twój rachunek w sklepie.
Na stronie PayPo sprawdź swoje dane i podaj pesel.
Po otrzymaniu zakupów decydujesz co ci pasuje, a co nie. Możesz zwrócić część albo całość zamówienia - wtedy zmniejszy się też kwota do zapłaty PayPo.
W ciągu 30 dni od zakupu płacisz PayPo za swoje zakupy bez żadnych dodatkowych kosztów. Jeśli chcesz, rozkładasz swoją płatność na raty.
Ten produkt nie jest dostępny w sklepie stacjonarnym
Symbol
308EYJ03527KS
Kod producenta
9781581121896
Autorzy
Chen Hung-Hsin
Rok wydania
2003
Elementy
140
Format
18.9x24.6cm
Język
angielski
This research of corporate strategy analysis implements comparative analysis and benchmarking to analyse and examine the corporate strategy of the pharmaceutical sectors of 4 international pharmaceutical companies. This research adopts the hybrid approach of combining qualitative and quantitative methods in a two stages research design. Quantitative method is applied first to deal with the comparative figures, and then qualitative method is used to find out the problem. The design of this multiple research includes three phases: data collection, analysis, and reporting. The findings of this research can be divided into 4 parts: R&D/marketing, technology alliances, strategic acquisitions and merger, and manufacturing. The drug innovative projects are recommended being developed within the company's familiar therapeutic areas in order to take its marketing advantage. Through this comparative analysis, some of this type of problems of these international pharmaceutical companies is identified. A big pharmaceutical company forming alliances with some small biotechnology companies has become a trend within pharmaceutical industry since 1980s. For pharmaceutical companies, to take advantage of R&D through biotechnology is the main purpose of alliances with small biotechnology companies. It is important to note that most pharmaceutical acquisitions belong to the type of absorption with high resource transferring and low autonomy. Due to the high profit margin and the essential importance of R&D and marketing, the operation management of manufacturing of pharmaceutical industry is relatively poor. The low asset utilisation rate pointed out this problem. Academic researches have revealed that existing theories of operation management of manufacturing, such as action research, set-up reduction, teamwork, continuous improvement, collaboration, and involvement, are applicable and beneficial to pharmaceutical industry rather than waiting for the technology breakthroughs.

EAN: 9781581121896
Potrzebujesz pomocy? Masz pytania?Zadaj pytanie a my odpowiemy niezwłocznie, najciekawsze pytania i odpowiedzi publikując dla innych.
Zapytaj o produkt
Jeżeli powyższy opis jest dla Ciebie niewystarczający, prześlij nam swoje pytanie odnośnie tego produktu. Postaramy się odpowiedzieć tak szybko jak tylko będzie to możliwe. Dane są przetwarzane zgodnie z polityką prywatności. Przesyłając je, akceptujesz jej postanowienia.
Napisz swoją opinię
Twoja ocena:
5/5
Dodaj własne zdjęcie produktu:
Prawdziwe opinie klientów
4.8 / 5.0 13732 opinii
pixel